NYSE:AVTRAvantor Stock Price, Forecast & News

Avantor's stock was trading at $12.92 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AVTR shares have increased by 40.6% and is now trading at $18.17. View which stocks have been most impacted by Coronavirus.

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 4 hold ratings and 20 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Avantor.

Avantor is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Avantor.

Avantor Inc (NYSE:AVTR) issued its earnings results on Wednesday, April, 29th. The company reported $0.17 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.15 by $0.02. The business earned $1.52 billion during the quarter, compared to analyst estimates of $1.45 billion. Avantor's revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter last year, the company earned $0.11 EPS. View Avantor's earnings history.

24 brokerages have issued twelve-month price objectives for Avantor's stock. Their forecasts range from $15.00 to $23.00. On average, they expect Avantor's stock price to reach $19.94 in the next year. This suggests a possible upside of 9.7% from the stock's current price. View analysts' price targets for Avantor.

News coverage about AVTR stock has been trending somewhat positive recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Avantor earned a daily sentiment score of 1.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutAvantor.

Avantor saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 8,640,000 shares, an increase of 6.7% from the April 30th total of 8,100,000 shares. Based on an average trading volume of 3,110,000 shares, the days-to-cover ratio is presently 2.8 days. Currently, 1.6% of the company's shares are short sold. View Avantor's Current Options Chain.

Some companies that are related to Avantor include Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO.B), Bio-Rad Laboratories (BIO), Waters (WAT), PerkinElmer (PKI), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Quanterix (QTRX), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Fluidigm (FLDM), Harvard Bioscience (HBIO) and Eyepoint Pharmaceuticals (EYPT). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Eastman Chemical (EMN), Alibaba Group (BABA), Home Depot (HD), Johnson & Johnson (JNJ), Procter & Gamble (PG), AT&T (T), CVS Health (CVS), Honeywell International (HON), Abbott Laboratories (ABT) and Cisco Systems (CSCO).

(AVTR) raised $3 billion in an IPO on Friday, May 17th 2019. The company issued 154,000,000 shares at a price of $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies served as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Avantor trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVTR."

Avantor's stock is owned by a number of institutional and retail investors. Top institutional investors include Nuveen Asset Management LLC (3.05%), Viking Global Investors LP (1.75%), Eminence Capital LP (1.03%), Maverick Capital Ltd. (0.98%), Third Point LLC (0.87%) and New South Capital Management Inc. (0.53%). Company insiders that own Avantor stock include Devashish Ohri, Gerard Brophy, Jo Natauri, Michael Wondrasch and New Mountain Investments Iii,. View institutional ownership trends for Avantor.

AVTR stock was sold by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Third Point LLC, Jennison Associates LLC, Mackay Shields LLC, Wells Fargo & Company MN, Balyasny Asset Management LLC, Loomis Sayles & Co. L P, and First Trust Advisors LP. Company insiders that have sold Avantor company stock in the last year include Devashish Ohri, Gerard Brophy, Jo Natauri, Michael Wondrasch, and New Mountain Investments Iii,. View insider buying and selling activity for Avantor.

AVTR stock was acquired by a variety of institutional investors in the last quarter, including Eminence Capital LP, New South Capital Management Inc., Country Trust Bank, Maverick Capital Ltd., Viking Global Investors LP, Peregrine Capital Management LLC, Obermeyer Wood Investment Counsel Lllp, and New York State Common Retirement Fund. View insider buying and selling activity for Avantor.

Shares of AVTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of AVTR stock can currently be purchased for approximately $18.17.

Avantor has a market capitalization of $10.45 billion and generates $6.04 billion in revenue each year. Avantor employs 12,000 workers across the globe.

The official website for Avantor is www.avantorsciences.com.

Avantor's mailing address is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. The company can be reached via phone at 610-386-1700 or via email at [email protected]